AI assistant
Sending…
CERUS CORP — Director's Dealing 2013
Mar 6, 2013
33349_dirs_2013-03-05_436adae0-eaf6-435a-9a92-67be8b26ac1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2013-03-01
Reporting Person: CORASH LAURENCE M (Director, Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-01 | Option (Right to Buy) | $3.66 | A | 170000 | Acquired | 2023-02-28 | Common Stock (170000) | Direct |
Footnotes
F1: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest thereafter on the monthly anniversary of the transaction date.
F2: Not applicable.
More from CERUS CORP
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 24
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 26